Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Inclusion and diversity in the PRINCIPLE trial

Patel MG. et al, (2021), The Lancet, 397, 2251 - 2252

Transformation of primary care during the COVID-19 pandemic: experiences of healthcare professionals in eight European countries.

Wanat M. et al, (2021), Br J Gen Pract

Probiotics to reduce antibiotic administration in care home residents aged 65 years and older: the PRINCESS RCT

Butler CC. et al, (2021)

Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? : A Randomized Trial.

Shepperd S. et al, (2021), Ann Intern Med

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

Yu L-M. et al, (2021)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Ramakrishnan S. et al, (2021), Lancet Respir Med

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan S. et al, (2021), Lancet Respiratory Medicine

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial.

Wang K. et al, (2021), Eur Respir J

Risk of adverse coronavirus disease 2019 outcomes for people living with HIV.

Mellor MM. et al, (2021), AIDS, 35, F1 - F10

Combination of the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial

Castro-Herrera VM. et al, (2021), Frontiers in Immunology, 12

Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial.

Gillespie D. et al, (2021), Br J Gen Pract

Does cranberry extract reduce antibiotic use for symptoms of acute uncomplicated urinary tract infections (CUTI)? A feasibility randomised trial

Gbinigie O. et al, (2021), BMJ Open, 11

Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: The POwER study

Dorward J. et al, (2021), BMJ Open, 11

Influenza and respiratory virus surveillance, vaccine uptake, and effectiveness at a time of cocirculating COVID-19: Protocol for the English primary care sentinel system for 2020-2021

De Lusignan S. et al, (2021), JMIR Public Health and Surveillance, 7

The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis

Dorward J. et al, (2021), The Lancet HIV

Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial.

Willcox M. et al, (2021), BMC Complement Med Ther, 21

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

Buchanan J. et al, (2021), Applied Health Economics and Health Policy

D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): Protocol for a randomised controlled trial

Franssen M. et al, (2021), BMJ Open, 11

Implementing interventions to reduce antibiotic use: A qualitative study in high-prescribing practices

Borek A. et al, (2021), BMC Family Practice

Load More

1
2
3
4
5
6
7
...
»